Shinichi Toyooka

发表

Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience.

Takao Hiraki, Hidefumi Mimura, Susumu Kanazawa, 2011, Acta medica Okayama.

Differential Inactivation of Caspase-8 in Lung Cancers

John D Minna, J. Minna, A. Gazdar, 2002, Cancer biology & therapy.

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells

Calum MacAulay, John D. Minna, David S. Shames, 2009, PloS one.

Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers

Stephen Lam, S. Lam, J. Minna, 2003, International journal of cancer.

Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

Nobuyoshi Shimizu, Hiroshi Date, Hiroaki Asano, 2006, Cancer research.

Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E.

Shigemi Matsumoto, Takashi Ninomiya, Shuta Tomida, 2018, The oncologist.

Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma.

Hiroaki Asano, Kazunori Tsukuda, J. Soh, 2011, Acta medica Okayama.

Genetic predictors of MEK dependence in non-small cell lung cancer.

William Pao, Barry S Taylor, Neal Rosen, 2008, Cancer research.

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

Kenichi Harada, Charles F Timmons, John D Minna, 2002, Oncogene.

DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies

Yingye Zheng, Ziding Feng, Adi F. Gazdar, 2004, Clinical Cancer Research.

Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

John D Minna, J. Minna, S. Toyooka, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer.

Nobuyoshi Shimizu, Kenji Shimizu, Hiroshi Date, 2008, Lung cancer.

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

William Pao, Yumei Pan, Lu Wang, 2012, Proceedings of the National Academy of Sciences.

The TP53 gene, tobacco exposure, and lung cancer

Toshihide Tsuda, S. Toyooka, A. Gazdar, 2003, Human mutation.